Communiqués

14/04 Renalytix : Fincial document - (RENX Half Year Report 26.03.26) PU
18/11 Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes PR
15/09/25 Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease PR
20/12/24 Renalytix : Result of AGM Form 8 K PU
26/11/24 Renalytix : Proxy Card 2024 (for holders of ADSs) PU
26/11/24 Renalytix : Depository Notice of AGM 2024 (for holders of ADSs) PU
26/11/24 Renalytix : FY24 Annual Report (June, 2024) PU
26/11/24 Renalytix : Notification letter November 2024 – AGM PU
26/11/24 Renalytix : Proxy Statement (Notice of AGM 2024) PU
20/11/24 Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025 PR
06/11/24 Renalytix : Result of General Meeting Form 8 K PU
11/10/24 Renalytix : Notification letter October 2024 PU
11/10/24 Renalytix : Shareholder circular and notice of GM (October 2024) PU
09/10/24 Renalytix plc - Commencement of trading on OTCQB in the United States AQ
08/10/24 Commencement of trading on OTCQB in the United States AQ
01/10/24 Renalytix : Update on financial results for the fiscal year ended 30 June 2024 Form 8 K PU
12/07/24 Form 8.5 (EPT/RI) - Renalytix Plc AQ
01/07/24 Pentwater Capital Management LP - Form 8.3 - Renalytix PLC PR
28/06/24 Pentwater Capital Management LP - Form 8.3 - Renalytix plc PR
27/06/24 Pentwater Capital Management LP - Form 8.3 - Renalytix Plc PR
26/06/24 Pentwater Capital Management LP - Form 8.3 - Renalytix Plc PR
26/04/24 Pentwater Capital Management LP - Form 8.3 - Renalytix PLC PR
03/04/24 Renalytix : Notification letter April 2024 PU
03/04/24 Form 8.5 (EPT/RI) - Renalytix plc AQ
15/03/24 Pentwater Capital Management LP - Form 8.3 - Renalytix Plc PR
Aucun résultat pour cette recherche